Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-176H8.1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ANKRD33B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | GNRH1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | POLR1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | TMEM184A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | CDKN3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | CTB-127M13.1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | CDH19 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | MCAM | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |